Neurotech International Limited
ASX:NTI.AX
Overview | Financials
Company Name | Neurotech International Limited |
Symbol | NTI.AX |
Currency | AUD |
Price | 0.05 |
Market Cap | 51,731,000 |
Dividend Yield | 0% |
52-week-range | 0.048 - 0.125 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Alexandra Andrews |
Website | https://www.neurotechinternational.com |
An error occurred while fetching data.
About Neurotech International Limited
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD